International Journal of Clinical Research

Objective To summarize the efficacy of Biantong Tablets combined with lactulose and bifidobacterium triple live bacteria in treating functional constipation in elderly patients with type 2 diabetes mellitus. Methods A total of 200 elderly patients with type 2 diabetes complicated with functional constipation treated in our hospital from January 2024 to May 2025 were selected and divided into two groups by the random number table method. The observation group received Biantong Tablets combined with lactulose and bifidobacterium triple live bacteria, while the control group received lactulose and bifidobacterium triple live bacteria. The therapeutic effects were analyzed. Results The treatment efficacy rate was 92.00% in the observation group, significantly higher than 80.00% in the control group (P<0.05). The time to symptom relief (abdominal distension, anal tenesmus, defecation time, and difficulty in defecation) was shorter in the observation group (P<0.05). The frequency of flatulence and defecation was higher in the observation group (P<0.05) at 48 hours and 96 hours. The recurrence rates at 1 month, 2 months, and 3 months after discontinuation were 5.00%,7.00%, and 10.00% in the observation group, significantly lower than 13.00%,17.00%, and 20.00% in the control group (P<0.05). Conclusion The combination of Biantong Tablets with lactulose and bifidobacterium triple live bacteria demonstrates significant efficacy in treating functional constipation in elderly patients with type 2 diabetes mellitus. It improves clinical symptoms, increases the frequency of flatulence and defecation, and has a low recurrence rate.

Biantong tablets; Lactulose; Bifidobacterium; Elderly patients with type 2 diabetes mellitus; Functional constipation; Treatment efficacy rate; Recurrence rate